Key Financial Inc’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-85
Closed -$15K 1020
2021
Q3
$15K Hold
85
0.01% 518
2021
Q2
$11K Hold
85
0.01% 561
2021
Q1
$12K Hold
85
0.01% 467
2020
Q4
$11K Buy
+85
New +$9.97K 0.01% 457
2020
Q2
Sell
-85
Closed -$7K 709
2020
Q1
$7K Buy
+85
New +$6.61K 0.01% 479

Key Financial Inc's XLRN Position: Q4 2021 in Review

Key Financial Inc sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 85 shares — an estimated $15K sold.

Key Financial Inc first reported a position in XLRN in Q1 2020 and held it in 5 quarters. The position peaked at $15K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Key Financial Inc reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Key Financial Inc sold 85 Acceleron Pharma shares in Q4 2021, an estimated $15K.
  • Key Financial Inc first reported a position in Acceleron Pharma in Q1 2020 and held it in 5 quarters.
  • Key Financial Inc's Acceleron Pharma position peaked at $15K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Key Financial Inc's 13F filing for Q4 2021, filed 19 Jan 2022.